Israel - hebreo - Ministry of Health

unipharm ltd, israel - pirfenidone - טבליה - pirfenidone 267 mg - pirfenidone

Israel - hebreo - Ministry of Health

unipharm ltd, israel - pirfenidone - טבליה - pirfenidone 801 mg - pirfenidone

Israel - hebreo - Ministry of Health

unipharm trading ltd, israel - pegfilgrastim - תמיסה להזרקה - pegfilgrastim 10 mg/ml - pegfilgrastim

Israel - hebreo - Ministry of Health

neopharm ltd, israel - lonafarnib - קפסולות ג'לטין קשיחות - lonafarnib 50 mg - lonafarnib

Israel - hebreo - Ministry of Health

neopharm ltd, israel - lonafarnib - קפסולות ג'לטין קשיחות - lonafarnib 75 mg - lonafarnib

Israel - hebreo - Ministry of Health

megapharm ltd - prednisolone - סירופ - prednisolone 3 mg / 1 ml - prednisolone - prednisolone - for glucocorticoid respousive inflamination as: endocrine disorders, rheumatic disorders, collagen diseases, dermatologic diseases, allergic states, ophthalmic diseases, respiratory diseases, hematologic disorders, neoplastic diseases, edematous states and gastrointestinal diseases.

Israel - hebreo - Ministry of Health

neopharm scientific ltd - lenalidomide - קפסולה קשיחה - lenalidomide 5 mg - lenalidomide - lenalidomide - 1. treatment of patients with transfusion-dependent anemia due to low- or intermediate - 1 - risk myelodysplastic syndromes associated with a deletion 5q cytogenetic abnormality with or without additional cytogenetic abnormality. 2. in combination with dexamethasone treatment of multiple myeloma patient who have received at least one prior therapy.

Israel - hebreo - Ministry of Health

neopharm scientific ltd - lenalidomide - קפסולה קשיחה - lenalidomide 5 mg - lenalidomide - lenalidomide - 1. treatment of patients with transfusion-dependent anemia due to low- or intermediate - 1 - risk myelodysplastic syndromes associated with a deletion 5q cytogenetic abnormality with or without additional cytogenetic abnormality. 2. in combination with dexamethasone treatment of multiple myeloma patient who have received at least one prior therapy.

Israel - hebreo - Ministry of Health

neopharm scientific ltd - lenalidomide - קפסולה קשיחה - lenalidomide 10 mg - lenalidomide - lenalidomide - 1. treatment of patients with transfusion-dependent anemia due to low- or intermediate - 1 - risk myelodysplastic syndromes associated with a deletion 5q cytogenetic abnormality with or without additional cytogenetic abnormality. 2. in combination with dexamethasone treatment of multiple myeloma patient who have received at least one prior therapy.

Israel - hebreo - Ministry of Health

neopharm scientific ltd - lenalidomide - קפסולה קשיחה - lenalidomide 10 mg - lenalidomide - lenalidomide - 1. treatment of patients with transfusion-dependent anemia due to low- or intermediate - 1 - risk myelodysplastic syndromes associated with a deletion 5q cytogenetic abnormality with or without additional cytogenetic abnormality. 2. in combination with dexamethasone treatment of multiple myeloma patient who have received at least one prior therapy.